TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
XGN

Exagen Inc

Healthcare · Diagnostics & Research

8.70$ +1.4% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow XGN
Line item 2013 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025
+22.6% +57.5% -23.8% +9.1% -19.2% -7.6% +73.6% +64.2% +39.2% -20.5% +22.9%
+83.6% +2.9% -34.8% -39.0% +401.8% +371.0% +75.5% -0.5% -23.1% -51.3% +22.4%
+339.2% +167.0% -93.7% -11.5% +258.1% +73.6% +118.9%
+120.7% -153.5% -867.8% -80.5% -1,046.5%
+277.3% +24.0% -29.6% -64.9% +102.5% +12.9% +420.9% +82.2% -80.8% -37.8% +24.5%
-218.2% +23.3% -36.3% -61.0% -48.2% +341.7% +431.9% +78.4% -81.4% -35.9% +21.6%
-97.9% +174.6%
-92.3% -100.0% -55.8% +4.3% -97.9% +174.6% -161.3% -36.9%
+23.2% -53.7% -0.3% -102.8% +80.4% +110.8% +32.6% +1,471.6% -92.1%
-26.8% +28.0% +80.6% -40.4% +501.7% -100.1% -100.8% +2,074.2% -93.8%
-162.8% -75.0% +2,964.0% -124.8% -188.0%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?